R. Kerwin

638 total citations
20 papers, 486 citations indexed

About

R. Kerwin is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, R. Kerwin has authored 20 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 7 papers in Cellular and Molecular Neuroscience and 3 papers in Molecular Biology. Recurrent topics in R. Kerwin's work include Schizophrenia research and treatment (5 papers), Bipolar Disorder and Treatment (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). R. Kerwin is often cited by papers focused on Schizophrenia research and treatment (5 papers), Bipolar Disorder and Treatment (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). R. Kerwin collaborates with scholars based in United Kingdom, Spain and United States. R. Kerwin's co-authors include H.-R. Olpe, Markus Schmutz, Peter V. Taberner, Graham J. Davies, A Maseri, John Clarke, M. H. Yacoub, D. Hackett, Stephen R. Bloom and D. Dawbarn and has published in prestigious journals such as The Lancet, American Journal of Psychiatry and European Heart Journal.

In The Last Decade

R. Kerwin

19 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Kerwin United Kingdom	9	240	167	140	77	67	20	486
Mitsuhiko Nakamura Japan	15	297 1.2×	194 1.2×	136 1.0×	62 0.8×	31 0.5×	37	564
Pilar Rosel Spain	15	219 0.9×	159 1.0×	161 1.1×	49 0.6×	19 0.3×	41	637
Hady Shimon Israel	9	105 0.4×	179 1.1×	110 0.8×	39 0.5×	12 0.2×	13	413
Perry J. Foreman United States	13	197 0.8×	54 0.3×	141 1.0×	18 0.2×	20 0.3×	18	467
Maria T. Caserta United States	11	112 0.5×	29 0.2×	99 0.7×	67 0.9×	22 0.3×	17	359
Michèle Kiesmann France	10	306 1.3×	216 1.3×	127 0.9×	17 0.2×	14 0.2×	22	528
C Schindler United States	15	295 1.2×	33 0.2×	114 0.8×	38 0.5×	40 0.6×	18	511
Jo Ann V. Antenor‐Dorsey United States	11	155 0.6×	33 0.2×	169 1.2×	38 0.5×	32 0.5×	16	564
Matthew Williams United Kingdom	8	143 0.6×	86 0.5×	237 1.7×	25 0.3×	14 0.2×	14	617
Roger S. Williams United States	9	134 0.6×	60 0.4×	181 1.3×	21 0.3×	13 0.2×	20	633

Countries citing papers authored by R. Kerwin

Since Specialization

Citations

This map shows the geographic impact of R. Kerwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Kerwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Kerwin more than expected).

Fields of papers citing papers by R. Kerwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Kerwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Kerwin. The network helps show where R. Kerwin may publish in the future.

Co-authorship network of co-authors of R. Kerwin

This figure shows the co-authorship network connecting the top 25 collaborators of R. Kerwin. A scholar is included among the top collaborators of R. Kerwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Kerwin. R. Kerwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mata, Ignácio F., M.J. Arranz, Luis Sierrasesúmaga, et al.. (2003). Serotonergic polymorphisms and psychotic disorders in populations from North Spain. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 126B(1). 88–94. 29 indexed citations

Sham, Pak C., et al.. (2003). [Influence of serotonergic transmission on response to olanzapine].. PubMed. 30(5). 265–71. 9 indexed citations

Mancama, Dalu, M J Arranz, Janet Munro, et al.. (2002). Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response. Neuroscience Letters. 333(3). 207–211. 52 indexed citations

Russell, Ailsa, et al.. (2002). IQ in childhood psychiatric attendees predicts outcome of later schizophrenia at 21 year follow‐up. Acta Psychiatrica Scandinavica. 106(2). 139–142. 27 indexed citations

Arranz, M J, Dalu Mancama, & R. Kerwin. (2001). Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)).. International Journal of Molecular Medicine. 7(1). 27–30. 4 indexed citations

Lingford‐Hughes, Anne, Paul D. Acton, S. Gacinovic, et al.. (2000). Levels of γ‐Aminobutyric Acid‐Benzodiazepine Receptors in Abstinent, Alcohol‐Dependent Women: Preliminary Findings From an ¹²³I‐Iomazenil Single Photon Emission Tomography Study. Alcoholism Clinical and Experimental Research. 24(9). 1449–1455. 32 indexed citations

Gutiérrez, Blanca, Jaume Bertranpetit, Roser Guillamat, et al.. (1997). Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder. American Journal of Psychiatry. 154(1). 113–115. 57 indexed citations

Stefanis, Nikos C., Janine Bresnick, R. Kerwin, & George McAllister. (1997). Quantitative analysis of dopamine D4 gene expression in control and schizophrenic post mortem tissue. Schizophrenia Research. 24(1-2). 88–88. 2 indexed citations

Eastwood, S.L., Richard H. Porter, Philip W. J. Burnet, R. Kerwin, & Paul J. Harrison. (1996). Non-NMDA glutamate receptor expression in schizophrenia. Schizophrenia Research. 18(2-3). 174–174. 3 indexed citations

10.

Shaikh, Shafaque, David Collier, & R. Kerwin. (1995). Homozygosity at the DRD3 does not influence response to clozapine. Schizophrenia Research. 15(1-2). 48–48. 1 indexed citations

11.

Shaikh, Shafaque, et al.. (1995). D4 polymorphisms in schizophrenic patients treated with clozapine. Schizophrenia Research. 15(1-2). 165–166. 3 indexed citations

12.

Arranz, María J., Katherine J. Aitchison, R. Kerwin, & David Collier. (1995). Analyses of clozapine response and the 5-HT2 gene. Schizophrenia Research. 15(1-2). 35–35. 1 indexed citations

13.

Kerwin, R., et al.. (1990). The role of nerve growth factor in Alzheimer's disease. Psychological Medicine. 20(2). 249–251. 1 indexed citations

14.

Clarke, John, R. Kerwin, S Larkin, et al.. (1987). CORONARY ARTERY INFUSION OF NEUROPEPTIDE Y IN PATIENTS WITH ANGINA PECTORIS. The Lancet. 329(8541). 1057–1059. 144 indexed citations

15.

Kerwin, R., Graham J. Davies, S Westaby, & R Foale. (1986). An unusual cardiac consequence of pancreatitis. European Heart Journal. 7(2). 176–178. 1 indexed citations

16.

Kerwin, R., et al.. (1985). Anomalous left coronary artery from the pulmonary artery presenting with infective endocarditis in an adult. European Heart Journal. 6(6). 545–547.

17.

Kerwin, R. & Peter V. Taberner. (1981). The mechanism of action of sodium valproate. General Pharmacology The Vascular System. 12(2). 71–75. 43 indexed citations

18.

Kerwin, R., H.-R. Olpe, & Markus Schmutz. (1980). THE EFFECT OF SODIUM‐n‐DIPROPYL ACETATE ON γ‐AMINOBUTYRIC ACID‐DEPENDENT INHIBITION IN THE RAT CORTEX AND SUBSTANTIA NIGRA IN RELATION TO ITS ANTICONVULSANT ACTIVITY. British Journal of Pharmacology. 71(2). 545–551. 69 indexed citations

19.

Kerwin, R. & C Pycock. (1978). Possible role of taurine as a transmitter of thermoregulation in the rat [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 282. 11P–12P. 1 indexed citations

20.

Cox, B., et al.. (1978). Behavioural changes induced by olfactory bulb ablation and intrabulbar injection of 5,6-DHT: susceptibility to psychotropic drugs [proceedings].. PubMed. 62(3). 400P–401P. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact